Post-chemoradiation surgical pathology stage can customize the surveillance strategy in patients with esophageal adenocarcinoma.

Abstract

Current algorithms for surveillance of patients with esophageal adenocarcinoma (EAC) after chemoradiation and surgery (trimodality therapy [TMT]) remain empiric. The authors hypothesized that the frequency, type, and timing of relapses after TMT would be highly associated with surgical pathology stage (SPS), and therefore SPS could be used to individualize… (More)

Topics

Cite this paper

@article{Taketa2014PostchemoradiationSP, title={Post-chemoradiation surgical pathology stage can customize the surveillance strategy in patients with esophageal adenocarcinoma.}, author={T. Taketa and Kazuki Sudo and A. Correa and Roopma Wadhwa and Hironori Shiozaki and Elena Elimova and Maria-Claudia Campagna and Mariela Anabel Blum and Heath Devin Skinner and Ritsuko U. Komaki and Jeffrey H M Lee and Manoop S. Bhutani and Brian R. Weston and David C. Rice and Stephen G. Swisher and Dipen M. Maru and Wayne Lewis Hofstetter and Jaffer A. Ajani}, journal={Journal of the National Comprehensive Cancer Network : JNCCN}, year={2014}, volume={12 8}, pages={1139-44} }